Amneal Pharmaceuticals In...

NASDAQ: AMRX · Real-Time Price · USD
9.43
0.04 (0.43%)
At close: Aug 15, 2025, 12:00 PM

Amneal Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-73.88M -48.72M -254.79M 10.62M
Depreciation & Amortization
236.19M 229.4M 240.18M 233.41M
Stock-Based Compensation
27.77M 26.82M 31.85M 28.41M
Other Working Capital
53.48M 47.15M 12.6M -17.02M
Other Non-Cash Items
109.08M 185.26M 107.81M 10.04M
Deferred Income Tax
n/a n/a n/a 83.39M
Change in Working Capital
-4.07M -47.19M -59.95M -133.59M
Operating Cash Flow
295.1M 345.58M 65.1M 241.82M
Capital Expenditures
-51.92M -69.19M -90.59M -52.64M
Cash Acquisitions
11.99M n/a -84.71M -146.54M
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-14.65M -22.39M -40.8M 5M
Investing Cash Flow
-63M -69.19M -174.31M -194.18M
Debt Repayment
-185.12M -196.35M -123.27M -78.18M
Common Stock Repurchased
-7.95M -2.38M -3.57M -2.66M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-27.83M -13.85M 20.22M -57.28M
Financial Cash Flow
-211.79M -212.57M -106.62M -138.12M
Net Cash Flow
19.31M 63.88M -221.51M -90.38M
Free Cash Flow
243.18M 276.39M -25.5M 189.18M